Literature DB >> 20482334

Measurement of sVEGF R1 and PlGF in serum: comparing prototype assays from Beckman Coulter, Inc. to R&D Systems microplate assays.

Donald Wothe1, Emanuel Gaziano, Shiraz Sunderji, Roberto Romero, Juan Pedro Kusanovic, Linda Rogers, Cheryl Hodges-Savola, Sean Roberts, James Wassenberg.   

Abstract

OBJECTIVE: To compare the performance of prototype Access® sVEGF R1 and PlGF automated immunoassays from Beckman Coulter to the Quantikine® microplate ELISA assays by R&D Systems.
METHODS: Samples obtained from pregnant women, non-pregnant women and men were assayed according to manufacturers' instructions.
RESULTS: Compared to the Quantikine assays, the Access assays demonstrated improved precision, increased sensitivity, broader dynamic ranges, and reduced analysis time. The Access assays were found to be specific for free sVEGF R1 and free PlGF.
CONCLUSION: There was good correlation between the Access and Quantikine assays. Superior performance by Access assays may have important prenatal diagnostic implications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482334      PMCID: PMC6548458          DOI: 10.3109/10641950903322881

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  22 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Authors:  Ravi Thadhani; Walter P Mutter; Myles Wolf; Richard J Levine; Robert N Taylor; Vikas P Sukhatme; Jeffrey Ecker; S Ananth Karumanchi
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

3.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1.

Authors:  Hans W Christinger; Germaine Fuh; Abraham M de Vos; Christian Wiesmann
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

5.  Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia.

Authors:  Thomas Krauss; Hans-Ulrich Pauer; Hellmut G Augustin
Journal:  Hypertens Pregnancy       Date:  2004       Impact factor: 2.108

6.  Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.

Authors:  Nick A Bersinger; Rønnaug A Ødegård
Journal:  Acta Obstet Gynecol Scand       Date:  2004-01       Impact factor: 3.636

7.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

8.  Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Jimmy Espinoza; Emmanuel Bujold; Yeon Mee Kim; Luis F Gonçalves; Ricardo Gomez; Samuel Edwin
Journal:  Am J Obstet Gynecol       Date:  2004-06       Impact factor: 8.661

9.  Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.

Authors:  Robert N Taylor; Jane Grimwood; Rennae S Taylor; Michael T McMaster; Susan J Fisher; Robyn A North
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

10.  Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

Authors:  Vassilis Tsatsaris; Frederic Goffin; Carine Munaut; Jean-François Brichant; Marie-Rose Pignon; Agnes Noel; Jean-Pierre Schaaps; Dominique Cabrol; Francis Frankenne; Jean-Michel Foidart
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

View more
  3 in total

Review 1.  Anti-angiogenesis and Preeclampsia in 2016.

Authors:  Susanne Schrey-Petersen; Holger Stepan
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

2.  The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.

Authors:  Allison L Cohen; Julia B Wenger; Tamarra James-Todd; Brooke M Lamparello; Elizabeth Halprin; Shanti Serdy; Shuling Fan; Gary L Horowitz; Kee-Hak Lim; Sarosh Rana; Tamara C Takoudes; Jennifer A Wyckoff; Ravi Thadhani; S Ananth Karumanchi; Florence M Brown
Journal:  Hypertens Pregnancy       Date:  2013-12-19       Impact factor: 2.108

3.  Time-specific placental growth factor (PlGF) across pregnancy and infant birth weight in women with preexisting diabetes.

Authors:  Tamarra James-Todd; Allison Cohen; Julia Wenger; Florence Brown
Journal:  Hypertens Pregnancy       Date:  2016-06-23       Impact factor: 2.108

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.